University of Aarhus: Heart Failure trials
The registry lists 26 Heart Failure studies with University of Aarhus as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 10Phase 4 1No phase 14(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Donor Derived Cell Free DNA (Dd-cfDNA) as a Biomarker for Allograft Rejection in Heart Transplant RecipientsEnrolling by invitationNCT07886489
- Vascular Complications After Kidney TransplantationRecruitingNCT07531966
- Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.RecruitingNCT05834803Not applicable
- Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Cardiovascular Effects.CompletedNCT05236335Not applicable
- Metabolic Effects of Chronic Ketosis (KETO-CHF Metabolic)CompletedNCT05161676Phase 2
- Hemodynamic Effects of Chronic Ketosis.CompletedNCT05161650Phase 2
- Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Metabolic Effects. (KETO-HFpEF-Metabolic)CompletedNCT05159570Not applicable
- Effects of Ketones and Niacin in Heart Failure PatientsCompletedNCT04703361Phase 2
- Weight-Adjusted Dosing of 3-OHB in Patients With Chronic Heart FailureStatus unknownNCT04594265Phase 2
- Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With NephropathyCompletedNCT04549324
- Cardiac Mitochondrial Function in Explanted Human HeartsStatus unknownNCT04500938
- Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Chronic Heart Failure: Cardiovascular EffectsStatus unknownNCT04443426Phase 2
- Treatment With the Ketone Body 3-hydroxybutyrate in Patients With Acute Heart FailureStatus unknownNCT04442555Phase 1
- Functional and Metabolic Effects of Ketone Bodies on Human Atrial Tissue in Patients With and Without Heart FailureStatus unknownNCT04379934Not applicable
- NT-proBNP Measurements to Rule-out Heart Failure Among Patients With Atrial Fibrillation: A Prospective Clinical StudyStatus unknownNCT04125966
- Ketones in Heart Failure - Effects on Cardiac EfficiencyCompletedNCT03073356Phase 2
- Electrophysiological Optimization of Left Ventricular Lead Placement in CRTCompletedNCT02346097Not applicable
- Effect of Remote Ischemic Conditioning in Patients With Chronic Ischemic Heart FailureCompletedNCT02248441Not applicable
- The Effects of Dobutamine on Postoperative Cardiac Function in Aortic Valve ReplacementSuspendedNCT01375335Phase 4
- Empiric Versus Imaging Guided Left Ventricular Lead Placement in Cardiac Resynchronization TherapyCompletedNCT01323686Not applicable
- The Effect of Heart Rate on Cardiac Index in Patients With Left Ventricular HypertrophyTerminatedNCT01241838Not applicable
- Optimized Glycemic Control in Heart Failure Patients With DM2:"Effect on Left Ventricular Function and Skeletal Muscle"CompletedNCT01213784Phase 2
- Modulation of Free Fatty Acids in Heart Failure Patients With Diabetes: "Effect on Left Ventricular Function"CompletedNCT01192373Phase 2
- The Effect of Hyperglycemia on LV Function and Exercise Capacity in Diabetics With and Without Heart Failure.CompletedNCT01071772Phase 2
- Effect of 4 Weeks Treatment With Acipimox in Patients With Chronic Heart FailureCompletedNCT00549614Not applicable
- Metabolic Modulation as Treatment in Acute Heart FailureTerminatedNCT00449423Phase 2